参考文献/References:
[1] Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classifica-tion of the epilepsies: position paper of the ILAE commis-sion for classification and terminology [J]. Epilepsia, 2017,58: 512-521.
[2] Bousser MG, Ferro JM. Cerebral venous thrombosis: anupdate [J]. Lancet Neurol, 2007, 6: 162-170.
[3] Devasagayam S, Wyatt B, Leyden J, et al. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study [J]. Stroke,2016, 47: 2180-2182.
[4] Khealani BA, Wasay M, Saadah M, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East [J]. Stroke, 2008, 39: 2707-2711.
[5] Sassi SB, Touati N, Baccouche H, et al. Cerebral venous thrombosis: a tunisian monocenter study on 160 patients [J].Clin Appl Thromb Hemost, 2016, 23: 1005-1009.
[6] Lee DJ, Ahmadpour A, Binyamin T, et al. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort [J]. Neuro-interv Surg, 2016, 9: 34-38.
[7] Erwin S, Susan T, Anousha R, et al. Influence of recanaliza-tion on outcome in dural sinus thrombosis: a prospectivestudy [J]. Stroke, 2004, 35: 544-547.
[8] Qureshi AI. A classification scheme for assessing recanali-zation and collateral formation following cerebral venous thrombosis [J]. J Vasc Interv Neurol, 2010, 3: 1-2.
[9] Strupp M, Covi K, Seelos M, et al. Cerebral venous thrombo-sis correlation between recanalization and clinical outcome:a long-term follow-up of 40 patients [J]. J Neurol, 2002, 249: 1123-1124.
[10] Arauz A, Vargas-Gonzalez JC, Arguelles-Morales N, et al.Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy [J]. J Neurol Neurosur Ps, 2016, 87: 247-251.
[11] Ferro JM, Bousser MG, Canh?o P, et al. European StrokeOrganization guideline for the diagnosis and treatment of cerebral venous thrombosis--endorsed by the European Academy of Neurology [J]. Eur J Neurol, 2017, 24: 1203-1213.
[12] Saposnik G, Barinagarrementeria F, Brown Jr RD, et al.Diagnosis and management of cerebral venous thrombosis: astatement for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke,2011, 42: 1158-1192.
[13] Sousa DA, Neto LL, Canh?o P, et al. Recanalization in cere-bral venous thrombosis: a systematic review and meta-analysis [J]. Stroke, 2018, 49: 1828-1835.
[14] Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis [J]. Eur J Neurol, 2016, 23(4): 681-687.
[15] Gazioglu S, Eyuboglu I, Yildirim A, et al. Cerebral venous sinus thrombosis clinical features, long-term outcome and recanalization [J]. J Clin Neurosci, 2017, 45: 248-251.
[16] Baumgartner R, Studer A, Arnold M, et al. Recanalisation of cerebral venous thrombosis [J]. J Neurol Neurosur Ps, 2003,74(4): 459-461.
[17] Putaala J, Hiltunen S, Salonen O, et al. Recanalization and its correlation to outcome after cerebral venous thrombosis[J]. J Neurol Sci, 2010, 292(1/2): 11-15.
[18] Coutinho JM, Ferro JM, Canhao P, et al. Cerebral venous and sinus thrombosis in women [J]. Stroke, 2009, 40: 2356-2361.
[19] Kenet G, Kirkham F, Niederstadt T, et al. Risk factors forrecurrent venous thromboembolism in the European colla-borative paediatric database on cerebral venous thrombosis: a multicentre cohort study [J]. Lancet Neurol, 2007, 6(7):595-603.
[20] R?ttger C, Bachmann G, Gerriets T, et al. A new model ofreversible sinus sagittalis superior thrombosis in the rat: magnetic resonance imaging changes [J]. Neurosurgery, 2005, 57: 573-580.
[21] 汤恒心，曹志恺，吕建平. 颅内静脉窦血栓形成动物模型建立及治疗实验研究[J]. 中国医学创新，2014，12：16-19.
[22] Mu SW, Dang Y, Fan YC, et al. Effect of HMGB1 and RAGEon brain injury and the protective mechanism of glycyrrhi-zin in intracranial sinus occlusion followed by mechanical thrombectomy recanalization [J]. Int J Mol Med, 2019, 44: 813-822.
[23] Wang W, Mu SW, Xu WM, et al. Establishment of a ratmodel of superior sagittal-sinus occlusion and recanaliza-tion via a thread-embolism method [J]. Neuroscience, 2019, 416: 41-49.